All Outputs (186)

Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers (2020)
Journal Article
Stickel, F., Lutz, P., Buch, S., Nischalke, H. D., Silva, I., Rausch, V., Fischer, J., Weiss, K. H., Gotthardt, D., Rosendahl, J., Marot, A., Elamly, M., Krawczyk, M., Casper, M., Lammert, F., Buckley, T. W., McQuillin, A., Spengler, U., Eyer, F., …Morgan, M. Y. (2020). Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers [Alcoholic cirrhosis, HCC, risk reduction and HSD17B13]. Hepatology, 72(1), 88-102. https://doi.org/10.1002/hep.30996

Background & Aims:
Carriage of rs738409:G in patatin-like phospholipase domain-containing 3 (PNPLA3) is associated with an increased risk for developing alcohol-related cirrhosis and hepatocellular carcinoma (HCC). Recently, rs72613567:TA in hydrox... Read More about Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers.

Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome (2020)
Journal Article
Moolla, A., de Boer, J., Pavlov, D., Amin, A., Taylor, A., Gilligan, L., Hughes, B., Ryan, J., Barnes, E., Hassan-Smith, Z., Grove, J., Aithal, G. P., Verrijken, A., Francque, S., Van Gaal, L., Armstrong, M. J., Newsome, P. N., Cobbold, J. F., Arlt, W., …Tomlinson, J. W. (2020). Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome [NAFLD and urinary steroids]. Alimentary Pharmacology and Therapeutics, 51(11), 1188-1197. https://doi.org/10.1111/apt.15710

Background: The development of accurate, non-invasive markers to diagnose and stage non-alcoholic fatty liver disease (NAFLD) is critical to reduce the need for an invasive liver biopsy and to identify patients who are at the highest risk of hepatic... Read More about Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome.

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort (2020)
Journal Article
Anstee, Q. M., Darlay, R., Cockell, S., Meroni, M., Govaere, O., Tiniakos, D., Burt, A. D., Bedossa, P., Palmer, J., Liu, Y.-L., Aithal, G. P., Allison, M., Yki-Järvinen, H., Vacca, M., Dufour, J.-F., Invernizzi, P., Prati, D., Ekstedt, M., Kechagias, S., …Daly, A. K. (2020). Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort [GWAS on NAFLD/NASH]. Journal of Hepatology, 73(3), 505-515. https://doi.org/10.1016/j.jhep.2020.04.003

Background and Aims

Genetic factors associated with non-alcoholic fatty liver disease (NAFLD) remain incompletely understood. To date, most GWAS studies have adopted radiologically assessed hepatic triglyceride content as reference phenotype and s... Read More about Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort.

HLA-B*14:01 and HLA-B*35:01 are associated with trimethoprim-sulfamethoxazole induced liver injury (2020)
Journal Article
Li, Y.-J., Phillips, E., Dellinger, A., Nicoletti, P., Schutte, R., Li, D., Ostrov, D. A., Fontana, R. J., Watkins, P. B., Stolz, A., Daly, A. K., Aithal, G. P., Barnhart, H., Chalasani, N., & Drug‐induced Liver Injury Network (DILIN). (2021). HLA-B*14:01 and HLA-B*35:01 are associated with trimethoprim-sulfamethoxazole induced liver injury [HLA risk alleles for TMP-SMX DILI]. Hepatology, 73(1), 268-281. https://doi.org/10.1002/hep.31258

Background and Aim
Trimethoprim‐sulfamethoxazole (TMP‐SMX) is an important cause of idiosyncratic drug induced liver injury (DILI), but its genetic risk factors are not well understood. We investigated the relationship between variants in the HLA C... Read More about HLA-B*14:01 and HLA-B*35:01 are associated with trimethoprim-sulfamethoxazole induced liver injury.

Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study (2020)
Journal Article
Newsome, P. N., Palmer, M., Freilich, B., Sheikh, M. Y., Sheikh, A., Sarles, H., Herring, R., Mantry, P., Kayali, Z., Hassanein, T., Lee, H.-M., & Aithal, G. P. (2020). Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study. Journal of Hepatology, 73(2), 231-240. https://doi.org/10.1016/j.jhep.2020.03.024

Background & Aims:
Volixibat is an inhibitor of the apical sodium-dependent bile acid transporter (ASBT), hypothesized to treat non-alcoholic steatohepatitis (NASH) by blocking bile acid reuptake and stimulating hepatic bile acid production.
Method... Read More about Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study.

L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis (2020)
Journal Article
Thiagarajan, P., Chalmers, J., Ban, L., Grindlay, D., & Aithal, G. P. (2020). L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis. World Journal of Meta-Analysis, 8(1), 4-14. https://doi.org/10.13105/wjma.v8.i1.4

BACKGROUND
Non-alcoholic fatty liver disease (NAFLD) dominates the landscape of modern hepatology. Affecting 25% of the general population, there is critical unmet need to identify broadly available, safe and cost-effective treatments. Cumulative ev... Read More about L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis.

HLA associations with infliximab-induced liver injury (2020)
Journal Article
Bruno, C. D., Fremd, B., Church, R. J., Daly, A. K., Aithal, G. P., Bjornsson, E. S., Larrey, D., Watkins, P. B., & Chow, C. R. (2020). HLA associations with infliximab-induced liver injury. Pharmacogenomics Journal, 20, 681–686. https://doi.org/10.1038/s41397-020-0159-0

Biomarkers that are able to identify patients at risk of drug-induced liver injury (DILI) after treatment with infliximab could be important in increasing the safety of infliximab use. We performed a genetic analysis to identify possible human leukoc... Read More about HLA associations with infliximab-induced liver injury.

The Evaluation and Use of a Food Frequency Questionnaire Among the Population in Trivandrum, South Kerala, India (2020)
Journal Article
Vijay, A., Mohan, L., Taylor, M. A., Grove, J. I., Valdes, A. M., Aithal, G. P., & Shenoy, K. T. (2020). The Evaluation and Use of a Food Frequency Questionnaire Among the Population in Trivandrum, South Kerala, India [Nutrient intake using food frequency questionnaires and its evaluation among the population in Trivandrum, South Kerala, India]. Nutrients, 12(2), 383. https://doi.org/10.3390/nu12020383

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Dietary record tools such as food frequency questionnaire (FFQ) and food diaries (FD) are the most commonly used choices for assessing dietary intakes in most large-scale epidemiological studi... Read More about The Evaluation and Use of a Food Frequency Questionnaire Among the Population in Trivandrum, South Kerala, India.

Acute Hyperenergetic, High-Fat Feeding Increases Circulating FGF21, LECT2, and Fetuin-A in Healthy Men (2020)
Journal Article
Willis, S. A., Sargeant, J. A., Yates, T., Takamura, T., Takayama, H., Gupta, V., Brittain, E., Crawford, J., Parry, S. A., Thackray, A. E., Varela-Mato, V., Stensel, D. J., Woods, R. M., Hulston, C. J., Aithal, G. P., & King, J. A. (2020). Acute Hyperenergetic, High-Fat Feeding Increases Circulating FGF21, LECT2, and Fetuin-A in Healthy Men [Hyper-energetic, high-fat feeding and hepatokines]. Journal of Nutrition, 150(5), 1076–1085. https://doi.org/10.1093/jn/nxz333

Background: Hepatokines such as fibroblast growth factor 21 (FGF21), leukocyte cell-derived chemotaxin 2 (LECT2), fetuin-A, fetuin-B and selenoprotein P (SeP) are liver-derived proteins which are modulated by chronic energy status and metabolic disea... Read More about Acute Hyperenergetic, High-Fat Feeding Increases Circulating FGF21, LECT2, and Fetuin-A in Healthy Men.

Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK (2019)
Journal Article
Rice, P., Williams, R., Newsome, P., Aithal, G., Morling, J., Alexander, G. J., Moriarty, K., Allison, M., McKee, M., Armstrong, I., MacGilchrist, A., Aspinall, R., McCloud, A., Baker, A., Mathews, M., Batterham, R., Kelly, D., Brown, K., Jarvis, H., …Yeoman, A. (2020). Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK. Lancet, 395(10219), 226-239. https://doi.org/10.1016/S0140-6736%2819%2932908-3

This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity, with high levels of hospital admissions which are worsening in deprived a... Read More about Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK.

Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven non-alcoholic steatohepatitis (2019)
Journal Article
Astbury, S., Atallah, E., Vijay, A., Aithal, G., Grove, J., & Valdes, A. (2020). Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven non-alcoholic steatohepatitis. Gut Microbes, 11(3), 569-580. https://doi.org/10.1080/19490976.2019.1681861

There is increasing evidence for the role of gut microbial composition in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis (NASH) is the most serious form of NAFLD where inflammation causes liver damage tha... Read More about Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven non-alcoholic steatohepatitis.

Obesity is the most common risk factor for chronic liver disease: Results from risk stratification pathway using transient elastography (2019)
Journal Article
Harris, R., Card, T. R., Delahooke, T., Aithal, G. P., & Guha, I. N. (2019). Obesity is the most common risk factor for chronic liver disease: Results from risk stratification pathway using transient elastography [Obesity: the most common risk factor for CLD]. American Journal of Gastroenterology, 114(11), 1744-1752. https://doi.org/10.14309/ajg.0000000000000357

Introduction
Obesity has been associated with liver fibrosis yet guidelines do not emphasise it as an independent risk factor in which to have a high index of suspicion of advanced disease. We aimed to elucidate the effect of a raised body mass inde... Read More about Obesity is the most common risk factor for chronic liver disease: Results from risk stratification pathway using transient elastography.

Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia (2019)
Journal Article
Serra-Burriel, M., Graupera, I., Torán, P., Thiele, M., Roulot, D., Wai-Sun Wong, V., Neil Guha, I., Fabrellas, N., Arslanow, A., Expósito, C., Hernández, R., Lai-Hung Wong, G., Harman, D., Darwish Murad, S., Krag, A., Pera, G., Angeli, P., Galle, P., Aithal, G., …Lammert, F. (2019). Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia. Journal of Hepatology, 71(6), 1141-1151. https://doi.org/10.1016/j.jhep.2019.08.019

Background & Aims: Nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) pose an important challenge to current clinical healthcare pathways due to a large number of at-risk patients. Therefore, we aimed to explore the cost-effec... Read More about Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia.

Glycemic, Gastrointestinal, Hormonal and Appetitive Responses to Pearl Millet or Oats Porridge Breakfasts: a Randomized, Crossover Trial in Healthy Humans (2019)
Journal Article
Alyami, J., Whitehouse, E., Yakubov, G. E., Pritchard, S. E., Hoad, C. L., Blackshaw, E., Heissam, K., Cordon, S. M., Bligh, H. F. J., Spiller, R. C., Macdonald, I. A., Aithal, G. P., Gowland, P. A., Taylor, M. A., & Marciani, L. (2019). Glycemic, Gastrointestinal, Hormonal and Appetitive Responses to Pearl Millet or Oats Porridge Breakfasts: a Randomized, Crossover Trial in Healthy Humans [Glycaemic, Gastrointestinal, Hormonal and Appetitive Responses to Pearl Millet or Oats Porridge Breakfasts: a Randomized, Crossover Trial in Healthy Humans]. British Journal of Nutrition. https://doi.org/10.1017/S0007114519001880

Whole grain cereal breakfast consumption has been associated with beneficial effects on glucose and insulin metabolism as well as satiety. Pearl millet is a popular ancient grain variety that can be grown in hot, dry regions. However, little is known... Read More about Glycemic, Gastrointestinal, Hormonal and Appetitive Responses to Pearl Millet or Oats Porridge Breakfasts: a Randomized, Crossover Trial in Healthy Humans.

Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community (2019)
Journal Article
Chalmers, J., Wilkes, E., Harris, R., Kent, L., Kinra, S., Aithal, G., Holmes, M., Johnson, J., Morling, J., & Guha, I. N. (2020). Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community. Frontline Gastroenterology, 11(2), 86-92. https://doi.org/10.1136/flgastro-2019-101177

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. Objective: To describe the development of the Nottingham liver disease stratification pathway, present a 12-month evaluation of uptake and stratification results... Read More about Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community.

Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug‐Induced Liver Injury (2019)
Journal Article
for the US DILIN Investigators., Bonkovsky, H. L., Severson, T., Nicoletti, P., Barnhart, H., Serrano, J., Chalasani, N., Fontana, R. J., Watkins, P. B., Navarro, V., Stolz, A., Daly, A. K., Aithal, G. P., & Odin, J. (2019). Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug‐Induced Liver Injury. Hepatology Communications, 3(8), 1032-1035. https://doi.org/10.1002/hep4.1382

With the application of genetic testing to contemporary medical diagnostics and practice, it has become apparent that the phenotypes of many disorders are modulated by host genetic factors. The aim of the current study was to determine whether select... Read More about Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug‐Induced Liver Injury.

Natural History of Histologically-proven Alcohol Related Liver Disease: A systematic review (2019)
Journal Article
Parker, R., Aithal, G. P., Becker, U., Gleeson, D., Masson, S., Wyatt, J. I., & Rowe, I. A. (2019). Natural History of Histologically-proven Alcohol Related Liver Disease: A systematic review [Systematic review: liver and non-liver mortality in hospitalized patients with histologically-proven alcohol related liver disease]. Journal of Hepatology, 71(3), 586-593. https://doi.org/10.1016/j.jhep.2019.05.020

Background:
Studies into the natural history of alcohol related liver disease (ArLD) to date have lacked long-term follow-up, large numbers of participants, or both. We performed a systematic review to summarise studies that describe the natural hi... Read More about Natural History of Histologically-proven Alcohol Related Liver Disease: A systematic review.

Of Potions, Poisons, Polygonum and Pre‐emptive Polymorphism (2019)
Journal Article
Aithal, G. P. (2019). Of Potions, Poisons, Polygonum and Pre‐emptive Polymorphism. Hepatology, 70(1), 8-10. https://doi.org/10.1002/hep.30798

There are scores of references to plants and herbs in William Shakespeare's plays; he was obviously very knowledgeable about their perceived effects. The secret to the highly potent love potion Oberon asks Puck to find, lies in the purple, yellow and... Read More about Of Potions, Poisons, Polygonum and Pre‐emptive Polymorphism.

Cohort profile: The Trivandrum Non-alcoholic Fatty Liver Disease (NAFLD) Cohort (2019)
Journal Article
Chalmers, J., Ban, L., Leena, K. B., Edwards, K. L., Grove, J. I., Aithal, G. P., & Shenoy, K. T. (2019). Cohort profile: The Trivandrum Non-alcoholic Fatty Liver Disease (NAFLD) Cohort. BMJ Open, 9(5), e027244. https://doi.org/10.1136/bmjopen-2018-027244

Purpose
The Trivandrum NAFLD cohort is a population-based study designed to examine the interaction between genetic and lifestyle factors and their association with increased risk of NAFLD within the Indian population.
Participants
Between 201... Read More about Cohort profile: The Trivandrum Non-alcoholic Fatty Liver Disease (NAFLD) Cohort.

Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges (2019)
Journal Article
Thiagarajan, P., & Aithal, G. P. (2019). Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges. Journal of Clinical and Experimental Hepatology, 9(4), 515-521. https://doi.org/10.1016/j.jceh.2019.03.002

Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of chronic liver disease in industrialized economies. With no licensed treatment currently available, together with a growing prevalence that parallels global increases in obesity and... Read More about Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges.